Home | Disease & Treatments | Cancer

Cancer Innovation - Step Into The Future

"The problem of cancer has long been a priority in medicine and, unfortunately, even many years will it remain so. In Russia, this is the second most cause of death. Nevertheless, support for cancer services by the state is inadequate, despite its remarkable growth ", - considers the pro-rector for Academic Affairs of Russian Medical Academy of Postgraduate Education Prof. Irina Poddubnaya. That is why in the fight against a deadly disease, doctors are increasingly joining forces not only with government agencies, but also with pharmaceutical companies working in the Oncology area. Using new technologies, achieved notable improvements in diagnosis, and treatment of many types of cancer.

"For a long time, I have been considered foreign pharmaceutical companies to our colleagues involved in collaborative work throughout the process to assist oncology patients", - said Poddubnaya. It seems that this view is shared by producers of oncology drugs. "Welcoming the initiatives of the Government to reform the health system and to reduce mortality from cancer, the company Bayer Schering Pharma is prepared to take this work very much involved.

With contribution to the common cause of cancer, we see the development and implementation of its own program "Development of cancer innovations" - "DCI". I think that our program will experience an unprecedented collaboration of public institutions and private businesses in the withdrawal of Russian health care system to a new level ", - said the head of Cancer directions Bayer Schering Pharma Ol'ga Glazkova.

In her view, the cancer area is located at the peak of innovation. A number of drugs are developed for the most effective "target" therapy. With widespread use of these drugs is associated 30% reduction in mortality from cancer in the West over the past decade.

"With pleasure I would like to say at the outset, that the liver cancer has been cured, - started by the head of the department of tumors of the liver and pancreas, Russian Cancer Research Center of RAMS, Professor Yuri Patyutko. - But on one condition: when a patient falls into the hands of specialists in time". To bring them to the data, where the size of a tumor less than 5 cm, the five-year survival rate is 70-75%, and half of these patients lived more than 10 years.

However, in his view, all indications point to further growth of liver cancer in Russia. It is necessary to use such technologies that would enable the process to diagnose in its early stages - in cases with tumors less than two centimeters in diameter, five-year survival rate approaching 100%. In addition, the possibility of a significant extension of life of inoperable patients, according to Patyutko, provides already existing drugs for developing.

Article Source: http://www.bo-knows.com

Liver cancer symptoms site tells about symptoms of the liver cancer and types of treatment. For more information visit: livercancersymptoms.org

Please Rate this Article

5 out of 54 out of 53 out of 52 out of 51 out of 5 

Not yet Rated